封面
市場調查報告書
商品編碼
1612569

生物製造中的病毒檢測和定量市場:按產品類型、技術、應用和最終用戶分類 - 2025-2030 年全球預測

Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物製造市場的病毒檢測和定量在2023年價值為26.7億美元,預計到2024年將達到28.9億美元,複合年成長率為8.40%,到2030年預計將達到47.1億美元。

生物製造病毒檢測和定量市場是生物技術領域的重要組成部分,專注於確保生物製藥製造的安全和品質。該市場包括先進的生物感測技術,例如 PCR、ELISA 和次世代定序,這些技術對於細胞培養物和生技藥品中病毒污染物的檢測和定量至關重要。對這些技術的需求源於嚴格的監管要求,以確保生物安全和產品功效,特別是在疫苗、基因治療和單株抗體的生產中。應用主要發生在臨床前和商業性製造環境中,其中準確的病毒檢測至關重要。關鍵的成長要素包括生物製藥行業的快速成長、研發投資的增加以及檢測開發的技術進步,為公司提供了創新快速檢測方法和自動化工作流程的機會。在預測分析中使用人工智慧和機器學習等新興趨勢為滿足對高通量、準確且經濟的解決方案不斷成長的需求提供了一個有前景的途徑。

主要市場統計
基準年[2023] 26.7億美元
預測年份 [2024] 28.9億美元
預測年份 [2030] 47.1億美元
複合年成長率(%) 8.40%

為了利用這些機會,公司應專注於開發多病原體檢測系統並增強樣品製備技術,以提高效率和可靠性。然而,先進檢測系統的高價格、缺乏標準化通訊協定以及結果解釋的複雜性等挑戰可能會阻礙市場擴張。監管障礙和對技術專業知識的需求也是主要限制因素。然而,投資聯合研發和夥伴關係可以減少這些障礙並促進創新和市場滲透。市場呈現出一個動態的格局,重點在於準確性、速度和成本效益。與相關人員保持密切合作,同時適應不斷變化的監管標準和技術進步的公司將有效克服生物製造病毒檢測和定量競爭市場中的挑戰,從而抓住成長機會。

市場動態:針對生物製造中快速發展的病毒檢測和定量市場揭示的關鍵市場見解

供需的動態交互作用正在改變生物製造中病毒檢測和定量的市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 病毒性疾病發生率不斷增加,需要增強檢測技術
    • 藥物研發和製造流程投資快速增加
    • 對可攜式和照護現場生命測試的需求不斷成長
  • 市場限制因素
    • 熟練人員缺乏,定量設備高成本
  • 市場機會
    • 病毒檢測和定量方法的快速進展
    • 重視病毒污染物的環境監測
  • 市場挑戰
    • 與病毒量分離相關的技術困難

波特五力:生物製造中病毒檢測與定量市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解生物製造中病毒檢測和定量市場的外部影響

外部宏觀環境因素在塑造生物製造市場病毒檢測和定量的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物製造中病毒檢測和定量市場的競爭狀況

對生物製造市場中病毒檢測和定量的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物製造病毒檢測與定量市場供應商績效評估

FPNV 定位矩陣是評估生物製造市場病毒檢測和定量供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物製造市場病毒檢測和定量的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對生物製造市場中的病毒檢測和定量進行策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 病毒性疾病發生率不斷增加,需要增強檢測技術
      • 藥物開發和製造流程的快速投資
      • 對可攜式和照護現場生命測試的需求增加
    • 抑制因素
      • 缺乏熟練人員及量化設備高成本
    • 機會
      • 病毒檢測和定量方法的快速進步
      • 重點關注病毒污染物的環境監測
    • 任務
      • 與病毒量分離相關的技術困難
  • 市場區隔分析
    • 優惠類型:高精度耗材的進步
    • 技術:改進PCR技術的採用以實現高特異性
    • 應用:疫苗和治療藥物製造的應用迅速增加
    • 最終用戶:CRO 和 CDMO 擴大採用病毒定量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按產品類型分類的生物製造市場中的病毒檢測和定量

  • 消耗品
    • 配件
    • 套件和檢測
  • 裝置
  • 服務

第7章生物製造中的病毒檢測和定量市場:按技術分類

  • 酵素免疫分析法
  • 流式細胞技術
  • 斑塊測定
  • 聚合酵素鏈鎖反應

第8章生物製造中的病毒檢測和定量市場:按應用分類

  • 血液及血液製品製造
  • 細胞/基因治療產品的製造
  • 幹細胞產品製造
  • 紙巾和紙巾產品製造
  • 疫苗及治療藥物製造

第9章生物製造中的病毒檢測和定量市場:按最終用戶分類

  • CRO 和 CDMO
  • 生命科學公司
  • 測試實驗室

第10章美洲生物製造的病毒檢測與定量市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區生物製造中的病毒檢測與定量市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲生物製造領域的病毒檢測和定量市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • 推出 DNAllergen即時PCR套件,用於可靠檢測目標過敏原序列
    • Virax Biolabs Group Limited 推出甲型禽流感病毒即時PCR檢測套組
    • 華大基因的新型螢光RT-PCR套件在澳洲核准用於檢測 COVID-19、甲型和乙型流感
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Charles River Laboratories
  • Danaher Corporation
  • Genscript Biotech Corporation
  • Hamilton Company
  • Illumina, Inc.
  • LG Chem, Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corp.
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Recipharm AB
  • Sartorius AG
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific LLC
  • Zymo Research Corporation
Product Code: MRR-5C6F41F5AF8D

The Biomanufacturing Viral Detection & Quantification Market was valued at USD 2.67 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 8.40%, to USD 4.71 billion by 2030.

The biomanufacturing viral detection and quantification market is a significant segment within the biotechnology sector, focusing on ensuring safety and quality in biopharmaceutical production. The scope encompasses advanced biosensing technologies, including PCR, ELISA, and next-generation sequencing, which are pivotal in detecting and quantifying viral contaminants in cell cultures and biologics. The necessity for these technologies arises from stringent regulatory demands ensuring biosafety and product efficacy, particularly in the production of vaccines, gene therapies, and monoclonal antibodies. Applications primarily occur in preclinical and commercial manufacturing settings, where accurate viral detection is crucial. Key growth factors include the burgeoning biopharmaceutical industry, increased R&D investments, and technological advancements in assay development, thus presenting opportunities for companies to innovate in rapid testing methods and automated workflows. Emerging trends such as the use of AI and machine learning in predictive analytics offer promising avenues for meeting the growing demand for high-throughput, accurate, and economical solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 4.71 billion
CAGR (%) 8.40%

To capitalize on these opportunities, businesses should focus on developing multi-pathogen detection systems and enhancing sample preparation techniques to increase efficiency and reliability. However, challenges such as the high cost of sophisticated detection systems, lack of standardized protocols, and complexity in interpreting results could impede market expansion. Regulatory hurdles and the need for technical expertise also pose significant constraints. Nonetheless, investing in collaborative R&D and partnerships can mitigate these barriers, fostering innovation and market penetration. The market presents a dynamic landscape with a focus on precision, speed, and cost-effectiveness. Companies that stay adaptable to evolving regulatory standards and technological advancements, while engaging in strong stakeholder collaborations, can effectively navigate challenges and leverage growth opportunities in the highly competitive market of biomanufacturing viral detection and quantification.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomanufacturing Viral Detection & Quantification Market

The Biomanufacturing Viral Detection & Quantification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of viral diseases and need for enhanced detection techniques
    • Exponential investments in drug development and manufacturing processes
    • Growing demand for portable and point-of-care vital testing
  • Market Restraints
    • Lack of skilled personnel and high cost of quantification devices
  • Market Opportunities
    • Rapid advancements in viral testing and quantification methods
    • Emphasis on environmental monitoring of viral contaminants
  • Market Challenges
    • Technical difficulties associated with the isolation of viral load

Porter's Five Forces: A Strategic Tool for Navigating the Biomanufacturing Viral Detection & Quantification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomanufacturing Viral Detection & Quantification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomanufacturing Viral Detection & Quantification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomanufacturing Viral Detection & Quantification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomanufacturing Viral Detection & Quantification Market

A detailed market share analysis in the Biomanufacturing Viral Detection & Quantification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomanufacturing Viral Detection & Quantification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomanufacturing Viral Detection & Quantification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomanufacturing Viral Detection & Quantification Market

A strategic analysis of the Biomanufacturing Viral Detection & Quantification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering Type, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Accessories and Kits & Assays.
  • Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay, and Polymerase Chain Reaction.
  • Based on Application, market is studied across Blood & Blood Products Manufacturing, Cellular & Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue & Tissue Products Manufacturing, and Vaccines & Therapeutics Manufacturing.
  • Based on End User, market is studied across CROs & CDMOs, Life Science Companies, and Testing Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
      • 5.1.1.2. Exponential investments in drug development and manufacturing processes
      • 5.1.1.3. Growing demand for portable and point-of-care vital testing
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid advancements in viral testing and quantification methods
      • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
    • 5.1.4. Challenges
      • 5.1.4.1. Technical difficulties associated with the isolation of viral load
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering Type: Advances in consumables for high accuracy
    • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
    • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
    • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Accessories
    • 6.2.2. Kits & Assays
  • 6.3. Instruments
  • 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Plaque Assay
  • 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Products Manufacturing
  • 8.3. Cellular & Gene Therapy Products Manufacturing
  • 8.4. Stem Cell Products Manufacturing
  • 8.5. Tissue & Tissue Products Manufacturing
  • 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

  • 9.1. Introduction
  • 9.2. CROs & CDMOs
  • 9.3. Life Science Companies
  • 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
    • 13.3.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
    • 13.3.3. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. BASF SE
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Charles River Laboratories
  • 7. Danaher Corporation
  • 8. Genscript Biotech Corporation
  • 9. Hamilton Company
  • 10. Illumina, Inc.
  • 11. LG Chem, Ltd.
  • 12. Lonza Group Ltd.
  • 13. Merck KGaA
  • 14. New England Biolabs
  • 15. Norgen Biotek Corp.
  • 16. Oxford Nanopore Technologies PLC
  • 17. PerkinElmer, Inc.
  • 18. Promega Corporation
  • 19. QIAGEN N.V.
  • 20. Recipharm AB
  • 21. Sartorius AG
  • 22. Shimadzu Corporation
  • 23. Takara Bio Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Thomas Scientific LLC
  • 26. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY PLAQUE ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STEM CELL PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TISSUE & TISSUE PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY VACCINES & THERAPEUTICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023